It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: HawkEyi
a reply to: rickymouse
Rather strange for the FDA to call it to prevent Covid as a disease and not virus.
originally posted by: carewemust
a reply to: HawkEyi
Re: www.fda.gov...
Holy smokes. It looks like all the FDA did is re-issue/renew the Emergency Use Authorization for the Pfizer vaccine, and added injection #3 as an authorized booster.
FDA’s analysis of the available efficacy data from 36,523
participants 12 years of age and older without evidence of SARS-CoV-2 infection prior to 7 days
after dose 2 confirmed the vaccine was 95% effective (95% credible interval 90.3, 97.6) in
preventing COVID-19 occurring at least 7 days after the second dose (with 8 COVID-19 cases in
the vaccine group compared to 162 COVID-19 cases in the placebo group).
FDA’s review of the available safety data
from 37,586 of the participants 16 years of age and older, who were followed for a median of
two months after receiving the second dose, did not identify specific safety concerns that would
preclude issuance of an EUA
On the basis of such
determination, the Secretary of HHS on March 27, 2020, declared that circumstances exist
justifying the authorization of emergency use of drugs and biological products during the
COVID-19 pandemic, pursuant to Section 564 of the Act (21 U.S.C. 360bbb-3), subject to terms
of any authorization issued under that section.2
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 43998 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Prevention
Official Title: A PHASE 1/2/3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND EFFICACY OF SARS-COV-2 RNA VACCINE CANDIDATES AGAINST COVID-19 IN HEALTHY INDIVIDUALS
Actual Study Start Date : April 29, 2020
Estimated Primary Completion Date : May 2, 2023
Estimated Study Completion Date : May 2, 2023
originally posted by: cmdrkeenkid
a reply to: rickymouse
The wording in this is clear. It's approved for ages 16 and up, and still authorized for experimental use in ages 12 through 15. I'm not arguing the effectiveness or lack thereof or any other aspect of the jab. This is simply about the thread author's simple misunderstanding of the legalese.
All descriptive printed matter, advertising, and promotional material, relating to the use of the Pfizer-BioNTech COVID‑19 Vaccine shall be consistent with the authorized labeling,as well as the terms set forth in this EUA, and meet the requirements set forth in section 502(a) and (n) of the FD&C Act and FDA implementing regulations.
originally posted by: Chalcedony
a reply to: carewemust
Then what is Comirnaty that they have approved for ages 12 and up after stating that the current Pfizer is still emergency authorized but now Comirnaty is fully approved and licensed?
originally posted by: drewlander
a reply to: HawkEyi
What dont you understand? Its 95% effective chief. *
* in 64% of all cases.
originally posted by: carewemust
originally posted by: Chalcedony
a reply to: carewemust
Then what is Comirnaty that they have approved for ages 12 and up after stating that the current Pfizer is still emergency authorized but now Comirnaty is fully approved and licensed?
Nothing is to be trusted without seeing the data that enabled the FDA to approve the drug.
originally posted by: Zitterbewegung
In conclusion. Who the hell would take this willingly? This was no real trial.